Related Experiment Video
Updated: May 22, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Amar Gajjar1, Anita Mahajan2, Tejus Bale3
1St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
The NCCN Guidelines offer updated recommendations for diagnosing and treating pediatric brain tumors, including diffuse high-grade gliomas and medulloblastomas. These guidelines ensure comprehensive, multidisciplinary care for children and adolescents with central nervous system cancers.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Clinical Practice Guidelines
Background:
- Pediatric central nervous system (CNS) cancers require specialized, multidisciplinary care.
- Existing guidelines need regular updates to reflect the latest research and clinical evidence.
Purpose of the Study:
- To summarize the evidence and expert consensus informing the NCCN Guidelines for Pediatric Central Nervous System Cancers.
- To provide a rationale for the diagnostic, staging, and treatment recommendations for specific pediatric brain tumors.
Main Methods:
- Review of current scientific literature and clinical trial data.
- Expert panel discussions and consensus-building among oncologists, neurosurgeons, and other specialists.
Main Results:
- Comprehensive recommendations for the workup, staging, and treatment of diffuse high-grade gliomas and medulloblastomas in pediatric patients.
- Integration of the latest evidence-based practices into clinical decision-making.
Conclusions:
- The NCCN Guidelines provide a vital framework for optimal management of pediatric CNS cancers.
- Adherence to these guidelines promotes standardized, high-quality care for affected children and adolescents.
Related Concept Videos
Standards of Care II
Treatment Resistant Cancers
Standards of Care I
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Targeted Cancer Therapies
There are several types of targeted therapies against...

